Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC TTA-A2 | 953778-63-7 | MFCD16628062 | 99.3% | 378.39 g/mol | C20H21F3N2O2 | 5 MG
Supplier: Medchemexpress LLC HY1118285MG
TTA-A2 is a potent, selective, orally active T-type voltage-gated calcium channel antagonist used in preclinical neuroscience research. It shows low-nanomolar potency against Cav3.1 and Cav3.2 channels and is supplied as a high-purity solid for laboratory use.
- Potent T-type calcium channel antagonist (IC50 ≈ 89-92 nM).
- Low-nanomolar potency against Cav3.1 and Cav3.2.
- High purity (~99.3%).
- Molecular weight 378.39 g/mol; formula C20H21F3N2O2.
- Solid form; powder stable at -20°C for up to 3 years.
- In solvent: stable at -80°C for 6 months or -20°C for 1 month.
- Intended for research use in studies of sleep disorders, epilepsy, and related neurological models.
- Available in small-mass quantities for in vitro and in vivo experiments.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?